Terpenoid ID | TKC152765 | |
Cell line | 0 | |
Protein target | 1 | |
DiseaseNCIT | 0 | |
ORDO | 0 | |
ICD | 11 |
ID | Cell Line | Synonyms | Value | Unit | Type | NCIt | ORDO |
---|---|---|---|---|---|---|---|
TKC152765 | HL-60 | HL 60; HL.60 HL60; Human Leukemia-60 | 12200.0 | nM | GI50 | C9154 | Orphanet_519 |
TKC152765 | SK-OV-3 | SKOV-3; SK-OV3; SK.OV.3; SKOV3; Skov3; SKO3 | 12700.0 | nM | GI50 | C7978 | |
TKC152765 | A549 | 11100.0 | nM | GI50 | C3512 | ||
TKC152765 | HT-29 | HT 29; HT29 | 13500.0 | nM | GI50 | C4349 | |
TKC152765 | RAW264.7 | RAW264 | 24.0 | % | Inhibition | C21604 | |
TKC152765 | HepG2 | 16.0 | U/L | Activity | C3728 | Orphanet_449 | |
TKC152765 | HepG2 2.2.15 | HEP-G2/2.2.15; Hep-G2/2215; HepG2/2215; HepG2-2.2.15; HepG2 2.2.15; HepG2.2.15; HepG2(2.2.15); 2.2.15 | 1787400.0 | nM | CC50 | C3728 | Orphanet_449 |
ID | Uniport | Pref_name | Gene name | value | unit | type |
---|---|---|---|---|---|---|
TKC152765 | Q9NPD5 | Solute carrier organic anion transporter family member 1B3 | SLCO1B3 | 90 | % | Inhibition |
TKC152765 | Q9Y6L6 | Solute carrier organic anion transporter family member 1B1 | SLCO1B1 | 112 | % | Inhibition |
TKC152765 | O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | IDH1 | 104 | % | Activity |
TKC152765 | P29477 | Nitric oxide synthase, inducible | Nos2 | >50000 | nM | IC50 |
TKC152765 | O42275 | Acetylcholinesterase | ache | -4 | % | Inhibition |
TKC152765 | P81908 | Cholinesterase | BCHE | -1 | % | Inhibition |
TKC152765 | Q96RI1 | Bile acid receptor | NR1H4 | 0 | nM | EC50 |
TKC152765 | Q8TDU6 | G-protein coupled bile acid receptor 1 | GPBAR1 | >0 | % | Efficacy |
Uniport ID | Uniport Name | ICD-11 |
---|---|---|
O75874 | IDHC_HUMAN | Acute myeloid leukaemia [ICD-11: 2A60] |
O75874 | IDHC_HUMAN | Liver cancer [ICD-11: 2C12] |
O75874 | IDHC_HUMAN | Malignant haematopoietic neoplasm [ICD-11: 2B33] |
O75874 | IDHC_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
O75874 | IDHC_HUMAN | Acute myeloid leukaemia [ICD-11: 2A60] |
O75874 | IDHC_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
Q96RI1 | NR1H4_HUMAN | Autoimmune liver disease [ICD-11: DB96] |
Q96RI1 | NR1H4_HUMAN | Cholelithiasis [ICD-11: DC11] |
Q96RI1 | NR1H4_HUMAN | Insomnia [ICD-11: 7A00-7A0Z] |
Q96RI1 | NR1H4_HUMAN | Osteoarthritis [ICD-11: FA00-FA05] |
Q96RI1 | NR1H4_HUMAN | Breast cancer [ICD-11: 2C60-2C6Y] |
Q96RI1 | NR1H4_HUMAN | Non-alcoholic fatty liver disease [ICD-11: DB92] |
Q96RI1 | NR1H4_HUMAN | Chronic kidney disease [ICD-11: GB61] |
Q96RI1 | NR1H4_HUMAN | Skeletal anomaly [ICD-11: LD24] |
Q96RI1 | NR1H4_HUMAN | Hepatic fibrosis/cirrhosis [ICD-11: DB93] |
Q96RI1 | NR1H4_HUMAN | Hyper-lipoproteinaemia [ICD-11: 5C80] |
Q96RI1 | NR1H4_HUMAN | Type 2 diabetes mellitus [ICD-11: 5A11] |
Q8TDU6 | GPBAR_HUMAN | Type 2 diabetes mellitus [ICD-11: 5A11] |
Q8TDU6 | GPBAR_HUMAN | Hepatic fibrosis/cirrhosis [ICD-11: DB93] |
Q8TDU6 | GPBAR_HUMAN | Metabolic disorder [ICD-11: 5C50-5D2Z] |